鶹ýӰ

Cardiology's Private Equity Hot Spots; Statin Overuse; Type B Blood & Heart Injury

— Recent developments of interest in cardiovascular medicine

MedpageToday
Cardio Break over a computer rendering of a heart.

Over one in 10 cardiology practices in several states -- Rhode Island, Nevada, Louisiana, Arizona, Oklahoma, Texas, and Florida -- have been . (JAMA Health Forum)

was tied to subsequent cardiovascular disease and type 2 diabetes. (European Journal of Preventive Cardiology)

Statins and PCKS9 inhibitors were associated with in a meta-analysis. (European Heart Journal)

A Japanese trial failed to show significant clinical benefit for (Vascepa) in statin users with coronary artery disease and low eicosapentaenoic acid levels. (Circulation)

A systematic review showed that at least one in five survivors of ischemic stroke and transient ischemic attack take . (Stroke)

for efficacy within the 4.5-hour window of acute ischemic stroke, albeit with an uptick in brain bleeds. (New England Journal of Medicine)

Elutia announced FDA clearance of EluPro, the first for the protection of pacemakers and defibrillators from future infections.

Researchers could not find evidence that was associated with poor heart transplant outcomes. (Journal of Cardiac Failure)

It takes about 20 cases for new operators to learn for coronary procedures. (Circulation: Cardiovascular Interventions)

Long-term excess mortality was not markedly higher for patients with treated with primary percutaneous coronary intervention and guideline-recommended secondary prevention therapies compared with the general population, a Danish registry showed. (Journal of the American College of Cardiology)

were linked to a lower incidence of epilepsy compared with other agents in patients with hypertension and no pre-existing stroke or cardiovascular disease. (JAMA Neurology)

Delivered via smartwatch, may help boost step counts for some people, but not others, according to a micro-randomized trial. (Circulation: Cardiovascular Quality and Outcomes)

Machine-learning algorithms were developed to detect based on oxygen saturation, perfusion, and pulse delay at two time points. (Journal of the American Heart Association)

were a predictor of sudden cardiac death in a detrended fluctuation analysis. (JACC: Clinical Electrophysiology)

RNF213 variants were identified as risk factors for . (JAMA Cardiology)

was disproportionately associated with myocardial injury after non-cardiac surgery in a retrospective analysis. (Scientific Reports)

  • author['full_name']

    Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine.